Skip to content

Prospective Physician-Initiated Observational Study of The Contact Detection System (CDS) in Patients Undergoing Radiofrequency Ablation Using the Niobe™ Remote Magnetic Navigation System

Prospective Physician-Initiated Observational Study of The Contact Detection System (CDS) in Patients Undergoing Radiofrequency Ablation Using the Niobe™ Remote Magnetic Navigation System (STAR)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03103945
Acronym
STAR
Enrollment
30
Registered
2017-04-07
Start date
2017-04-01
Completion date
2017-11-23
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Catheter Ablation

Keywords

Atrial Fibrillation, Atrial Arrhythmia, Arrhythmias, Cardiac, Cardiac Diseases, Electrophysiologic Techniques, Cardiac, Electrophysiology, Remote Magnetic Navigation, Contact Detection System

Brief summary

This observational study evaluates peri-procedural results of the Niobe™ Remote Magnetic Navigation (RMN) ES system using the contact detection system (CDS) in patients undergoing standard of care radiofrequency ablation of cardiac arrhythmias. The objective of this observational study is to confirm system performance of the CDS and that it does not alter pacing, electrocardiograms, or mapping during RF ablation procedures.

Interventions

DEVICECDS box connection of the Niobe™ Remote Magnetic Navigation System

For all subjects included in the study, the ablation procedure will be started per standard of care. First mapping, pacing and electrocardiograms of the right atrium will be evaluated without the CDS box connected. Second the CDS box will be connected to the catheter and mapping, pacing and electrocardiograms will be recorded again. Next, ablation will be conducted per standard of care.

Sponsors

Erasmus Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with a clinical indication for RF ablation of cardiac arrhythmias with the Niobe Remote Magnetic Navigation system * patients referred to one of the participating ablation centers * written informed consent

Exclusion criteria

* presence of a atrial thrombus or left atrial appendage (LAA) thrombus seen on (contrast) echocardiography or MRI * contra-indication for general anesthesia * age below 18 years

Design outcomes

Primary

MeasureTime frameDescription
Mapping qualityOne day - during ablation procedurePhysician's and technician's subjective score of the quality of mapping the right atrium without CDS box connected and with CDS box connected
Pacing thresholdsOne day - during ablation procedurePacing thresholds of three separate areas of the right atrium without CDS box connected and pacing thresholds of the same three areas with CDS box connected
Pacing captureOne day - during ablation procedurePacing capture of three separate areas of the right atrium without CDS box connected and pacing capture of the same three areas with CDS box connected
Electrocardiograms10 months - ECGs will be evaluated after inclusion is completedDifference between and disturbance of the intracardiac electrocardiograms without the CDS box connected versus with the CDS box connected, evaluated by two independent and blinded electrophysiologists

Secondary

MeasureTime frameDescription
Number of procedure related minor adverse events, attributed to the CDS system30 daysMinor adverse events: post procedural precordial pain, phrenic nerve injury, minor bleeding - type II
Number of acute procedure succes1 day - during ablation procedureNumber of procedures with successful electrical isolation of ablated area
Number of procedure related major adverse events, attributed to the CDS system30 daysMajor adverse events: death, acute myocardial infarction (AMI) or coronary artery damage, major bleeding - type III and V, abdominal bleeding, tamponade \> 80cm3, late tamponade, ischemic cerebral event

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026